Using ultra-low field MRI to assess brain conditions
Official title: Ultra-Low Field (ULF) Point Of Care (POC) MRI System for Study Brain Morphology and Pathology
Run by National Institutes of Health Clinical Center (CC) · NCT06203626 · Data updated 2026-11-12
This study is testing a new type of MRI that uses lower magnetic fields to see if it can better detect brain problems in people of all ages, including those with neurological symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Years to 99 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | March 26, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT06203626 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 3 years and older who have neurological symptoms or are healthy volunteers.
✕Probably not a fit
Patients with conditions that do not involve neurological disorders or those unable to comply with study procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of an ultra-low field MRI (ULF-MRI) system in detecting neurological disorders compared to standard MRI techniques. Participants aged 3 years and older, including both healthy individuals and those with neurological symptoms, will undergo two MRI exams: one standard and one ULF-MRI. The study will analyze the sensitivity of ULF-MRI in identifying brain pathologies and will also collect data on participants' social determinants of health. The ultimate goal is to enhance access to neuroimaging and improve early intervention strategies for neurological diseases.
Why it matters
Potential benefit: If successful, this study could improve access to MRI diagnostics for patients with neurological conditions, particularly those facing barriers to traditional imaging.
How similar studies have gone: While the use of ultra-low field MRI is a novel approach, similar studies have shown promise in improving access to imaging technologies.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Stated willingness to comply with all study procedures and availability for the duration of the study. * Volunteer of any gender, 3 years of age and older. * Adult participant: must be capable of understanding the procedures and requirements of this study and be able and willing to sign an informed consent document. * Minor participant: Must have a parent or guardian capable of understanding the procedures and requirements of this study who are willing to sign an informed parental consent document, and where feasible, the minor age 7 and older provides assent. * Either: * Adult in good general health as evidenced by medical history or * Diagnosed with a stroke, a neurological or neuro-oncological disease, or * Exhibiting symptoms suggestive of neurological or neuro-oncological disease. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * Unable to undergo MRI study based on screening (e.g., presence of non-MRI compatible objects). * Pregnancy or lactation, if contrast agent is required.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Silvina G Horovitz, Ph.D. — National Institute of Neurological Disorders and Stroke (NINDS)
- Study coordinator: Ruli Zhang
- Email: zhangr@ninds.nih.gov
- Phone: (301) 435-6028
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
VLCPUFA-rich fish oil and standard DHA oil: who reaches a higher omega-3 index?
This study tests whether VLCPUFA-rich fish oil raises the blood omega-3 index more than a standard DHA-rich fish oil in healthy adults aged 18–60.
-
Blood biomarkers for immune-related neuropsychiatric conditions
This study tests whether blood biomarkers can help identify neuropsychiatric disorders that may be linked to the immune system in people of any age.
-
First-in-human imaging of PDE4D with [11C]JMJ-129-d2 in healthy volunteers
A new PET tracer called [11C]JMJ-129-d2 is being tested in healthy adults to see if it safely and reliably images the brain’s PDE4D enzyme and to measure how the tracer distributes in the body.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Augmenting Parent Management Training with a Smartphone Tool
This study tests whether adding a smartphone app to parent management training helps reduce irritability and temper outbursts in kids aged 8–13 with disruptive behavior disorders.
-
How healthy adults look at faces and other images with their eyes
This study tests how healthy adults direct their gaze and pay attention to visual images, including faces, to see how basic visual features influence eye movements.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.